Concepedia
Statistics
Publications
45
Citations
5.9K
H-Index
26
Active since
2002
Affiliations
Cornell University(Current)
Massachusetts Institute of Technology
University of Campania "Luigi Vanvitelli"
Harvard–MIT Division of Health Sciences and Technology
Columbia University Irving Medical Center
Christopher A. Alabi is an author at Cornell University specializing in pharmacy, drug delivery, and pharmaceutics.
Publications per year
2002–2024
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Mark E. Davis, Jonathan E. Zuckerman, Chung Hang Jonathan Choi et al. · Nature · 2010 · 2.5K citations · Full text
Pharmacy, Molecular Pharmaceutics, Pharmacology +12
Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles
Chung Hang Jonathan Choi, Christopher A. Alabi, Paul Webster et al. · Proceedings of the National Academy of Sciences · 2009 · 687 citations · Full text
Pharmacy, Oncology, Pharmaceutics +17
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
Yizhou Dong, Kevin T. Love, J. Robert Dorkin et al. · Proceedings of the National Academy of Sciences · 2014 · 481 citations · Full text
Pharmacy, Pharmaceutics, Pharmacology +16
Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets
Rory D. de Vries, Katharina S. Schmitz, Francesca T. Bovier et al. · Science · 2021 · 221 citations · Full text
Life Sciences, Infectious Diseases, Molecular Biology +16
Sequence-Defined Polymers via Orthogonal Allyl Acrylamide Building Blocks
Mintu Porel, Christopher A. Alabi · Journal of the American Chemical Society · 2014 · 213 citations
Natural Sciences, Chemistry, Polymer Chemistry +15
1–5 of 45